会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • INJECTION-MOLDED DOSAGE FORM
    • 注射剂型剂型
    • WO2013055668A1
    • 2013-04-18
    • PCT/US2012/059323
    • 2012-10-09
    • DOW GLOBAL TECHNOLOGIES LLC
    • READ, Michael, D.COPPENS, Karen, A.HALL, Mark, J.ZHAO, Jin
    • C08L1/28A61K9/48C08L5/00
    • A61K9/4816A61K9/4833A61K9/4883C08K5/0016C08K5/05C08L1/28C08L1/286C08L5/00
    • An injection-molded shell of a dosage form of good quality is producible by a) providing a composition comprising i) from 25 to 90 weight percent of ethylcellulose, ii) from 7.5 to 60 weight percent of a polysaccharide or polysaccharide derivative being different from ethylcellulose, and iii) from 2.5 to 50 weight percent of at least one component being different from polysaccharides and polysaccharide derivatives, based on the total weight of the composition, with the proviso that the composition comprises zero or not more than 10 weight percent of gelatin and zero or not more than 10 weight percent of a polymer comprising homo- or copolymerized acrylic acid, homo- or copolymerized methacrylic acid, a homo- or copolymerized acrylate or a homo- or copolymerized methacrylate, and b) subjecting the composition to shearing and heat to plasticize the composition and injection- molding the plasticized composition into a three-dimensional shell of a dosage form.
    • 具有良好质量的剂型的注射成型的外壳可以通过以下方式生产:a)提供组合物,其包含i)25至90重量%的乙基纤维素,ii)7.5至60重量%的不同于乙基纤维素的多糖或多糖衍生物 ,和iii)基于组合物的总重量,2.5至50重量%的至少一种与多糖和多糖衍生物不同的组分,条件是组合物包含零或不大于10重量%的明胶和 0或不超过10重量%的包含均聚或共聚的丙烯酸,均聚或共聚的甲基丙烯酸,均聚或共聚的丙烯酸酯或均聚或共聚的甲基丙烯酸酯的聚合物的聚合物,和b)使组合物经受剪切和加热 塑化组合物并将增塑组合物注塑成剂型的三维壳。
    • 6. 发明公开
    • INJECTION-MOLDED DOSAGE FORM
    • SPRITZGEGOSSENE DARREICHUNGSFORM
    • EP2766423A1
    • 2014-08-20
    • EP12783442.2
    • 2012-10-09
    • Dow Global Technologies LLC
    • READ, Michael, D.COPPENS, Karen, A.HALL, Mark, J.ZHAO, Jin
    • C08L1/28A61K9/48C08L5/00
    • A61K9/4816A61K9/4833A61K9/4883C08K5/0016C08K5/05C08L1/28C08L1/286C08L5/00
    • An injection-molded shell of a dosage form of good quality is producible by a) providing a composition comprising i) from 25 to 90 weight percent of ethylcellulose, ii) from 7.5 to 60 weight percent of a polysaccharide or polysaccharide derivative being different from ethylcellulose, and iii) from 2.5 to 50 weight percent of at least one component being different from polysaccharides and polysaccharide derivatives, based on the total weight of the composition, with the proviso that the composition comprises zero or not more than 10 weight percent of gelatin and zero or not more than 10 weight percent of a polymer comprising homo- or copolymerized acrylic acid, homo- or copolymerized methacrylic acid, a homo- or copolymerized acrylate or a homo- or copolymerized methacrylate, and b) subjecting the composition to shearing and heat to plasticize the composition and injection-molding the plasticized composition into a three-dimensional shell of a dosage form.
    • 具有良好质量的剂型的注射成型的外壳可以通过以下方法生产:a)提供组合物,该组合物包含i)25至90重量%的乙基纤维素,ii)7.5至60重量%的不同于乙基纤维素的多糖或多糖衍生物 ,和iii)基于组合物的总重量,2.5至50重量%的至少一种与多糖和多糖衍生物不同的组分,条件是组合物包含零或不超过10重量%的明胶和 0或不超过10重量%的包含均聚或共聚的丙烯酸,均聚或共聚的甲基丙烯酸,均聚或共聚的丙烯酸酯或均聚或共聚的甲基丙烯酸酯的聚合物的聚合物,和b)使组合物经受剪切和加热 塑化组合物并将增塑组合物注模成剂型的三维壳体。